医疗保健 CMO 市场、医疗保健 CMO 市场规模、医疗保健 CMO 市场份额、医疗保健 CMO 市场预测、医疗保健 CMO 市场增长、医疗保健 CMO 市场分析市场概览、增长、趋势、分析、研究报告(2023 年至 2031 年)

  • Report Code : TIPRE00003263
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计到 2031 年,医疗保健 CMO 市场规模将从 2023 年的 1382.4 亿美元增至 3852.6 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 13.7%。市场整合的不断加剧以及并购的增多可能仍是市场的主要趋势。

医疗保健CMO市场分析

由于生物技术和创新疗法的进步,生物制药和生物制剂领域对合同制造组织 (CMO) 服务的需求日益增长。复杂而专业的分子(包括高效药物和个性化药物)的兴起,增加了对具有管理复杂制造流程专业知识的 CMO 的需求。医疗保健 CMO 市场正变得越来越全球化,公司正在寻求与不同地区的 CMO 合作,以从成本效益、监管优势和进入不同市场的机会中获益。

医疗保健 CMO 市场概览

CMO 提供与开发、制造和包装药品、生物技术产品、医疗器械和其他医疗保健产品相关的服务。医疗保健行业正趋向于增加对 CMO 的外包。公司利用 CMO 的专业知识和技能来简化制造流程并专注于核心竞争力。提供灵活且可扩展的制造解决方案的 CMO 很受欢迎。适应不同的生产规模和计划对于制药和生物技术公司来说至关重要。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

医疗保健 CMO 市场:

Healthcare CMO Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

医疗保健 CMO 市场驱动因素和机遇

老年人口增加,加上药品和医疗器械产量增加,市场前景看好

世界各地的老年人口数量一直在大幅增加。根据联合国公布的数据,老年人口估计每年以 3% 的速度增长。欧洲和亚太地区 60 岁及以上老年人口最多。此外,预计世界老龄人口将从 2030 年的 14 亿增至 2050 年的 21 亿。衰老与心血管、糖尿病、癌症等各种慢性疾病有关。因此,这些年龄段的人对治疗产品和医疗设备的需求也在增加。因此,由于全球需求不断增长,上述因素预计将推动医疗保健 CMO 市场的发展。

生物仿制药不断发展带来的增长机会

生物仿制药越来越受到青睐,因为消费者希望获得明显的成本节约,并且为替代制药商提供了进入成熟市场和新兴市场的机会。技术进步和对癌症、类风湿性关节炎等疾病的理解不断提高,导致对生物仿制药和生物制剂开发的需求增加。为了满足尚未满足的条件,许多公司正在大力投资生物制剂制造,以产生更高的收入。中国、印度、澳大利亚和韩国等新兴国家拥有最大的生物技术中心,并且由于新兴参与者的出现,市场正在增长。因此,这些公司更愿意将制造服务外包给 CMO,以节省生物制剂和生物仿制药开发过程中测试服务所需的内部成本和时间。这种倾向于 CMO 而非内部制造的转变预计将在未来几年增加全球 CMO 的增长机会。

医疗保健 CMO 市场报告细分分析

有助于得出医疗保健 CMO 市场分析的关键部分是基于服务。

  • 根据服务,医疗保健 CMO 市场分为制药合同制造服务和医疗器械合同制造服务。制药合同制造服务进一步分为活性药物成分 (API)、最终剂型制造和包装。同样,医疗器械合同制造服务细分为外包设计、设备制造和最终产品组装。制药合同制造服务部门在 2023 年占据最大市场份额,预计在预测期内将实现最高复合年增长率。

医疗保健 CMO 市场份额(按地区)分析

医疗保健CMO市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美在医疗 CMO 市场中占据主导地位。北美医疗 CMO 市场的增长得益于制药、生物制药和医疗器械行业的增长、有利的条件以及监管良好的医疗保健行业。美国在 2023 年占据了最大的市场份额。美国是制药和生物制药行业最大的市场,约占全球市场的三分之一。美国在生物制药研发活动方面被誉为世界领先者。此外,政府的支持增强了制药和生物制药的合同制造。这有助于推动公司开发对公共健康和安全必不可少的药物、对策和相关诊断。此外,复杂设备制造的增加使人们摆脱了日常担忧,可以将更多的精力和精力放在公司的核心技术上,从而促进该地区的市场增长。

 

医疗保健 CMO 市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响医疗保健 CMO 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的医疗保健 CMO 市场细分和地理位置。

Healthcare CMO Market
  • 获取医疗保健 CMO 市场的区域特定数据

医疗保健 CMO 市场报告范围

报告属性细节
2023 年的市场规模1382.4亿美元
2031 年市场规模3852.6亿美元
全球复合年增长率(2023 - 2031)13.7%
史料2021-2022
预测期2024-2031
涵盖的领域按服务
  • 医药合同制造服务
  • 医疗器械合同制造服务
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 荷兰皇家帝斯曼集团
  • 康泰伦特公司
  • 勃林格殷格翰国际有限公司
  • Recipharm AB (上市公司)
  • 法雷瓦
  • 龙沙
  • 皮拉马尔企业有限公司
  • 雷迪博士

市场参与者密度:了解其对商业动态的影响

医疗保健 CMO 市场正在快速增长,这得益于最终用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在医疗保健 CMO 市场运营的主要公司有:

  1. 荷兰皇家帝斯曼集团
  2. 康泰伦特公司
  3. 勃林格殷格翰国际有限公司
  4. Recipharm AB (上市公司)
  5. 法雷瓦
  6. 龙沙

免责声明上面列出的公司没有按照任何特定顺序排列。


Healthcare CMO Market

 

  • 获取医疗保健 CMO 市场顶级关键参与者概览

医疗保健 CMO 市场新闻和最新发展

医疗保健 CMO 市场通过收集主要和次要研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。医疗保健 CMO 市场的一些发展情况如下:

  • Kühne Holding AG 已与领先的国际投资公司 BC Partners 达成最终协议,收购制药合同开发和制造组织 Aenova Group。作为交易的一部分,BC Partners 的建议基金将与 Kühne Holding AG 一起进行再投资,并继续作为少数股东支持 Aenova。财务条款尚未披露。Aenova 集团是制药和医疗保健行业全球领先的 CDMO(合同开发和制造组织)之一。(BC Partners,新闻,2024 年 4 月)
  • 加拿大最大的制药公司 Pharmascience 宣布,其 Candiac 工厂将斥资 1.2 亿美元进行无菌注射剂生产设施的大规模扩建。继这一重要里程碑之后,该公司现在自豪地宣布,将扩大其合同开发和制造组织 (CDMO) 服务,并成立一个专门从事注射剂产品的新业务部门。(Pharmascience Inc.,新闻,2024 年 2 月)
  • 丹纳赫集团宣布达成最终协议,以约 96 亿美元的现金收购私人控股公司 Aldevron,丹纳赫预计将使用现金和/或发行商业票据的收益为收购提供资金。(丹纳赫集团,新闻稿,2021 年 6 月)

医疗保健 CMO 市场报告覆盖范围和交付成果

“医疗 CMO 市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

  • 医疗 CMO 市场规模及全球、区域和国家层面所有关键细分市场的预测
  • 医疗保健 CMO 市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 医疗保健 CMO 市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及医疗 CMO 市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the healthcare CMO market in 2023?

The North America region dominated the healthcare CMO market in 2023.

What are the driving factors impacting the healthcare CMO market?

Increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices are the driving factors impacting the healthcare CMO market.

What are the future trends of the healthcare CMO market?

Growing market consolidation and rise in the mergers and acquisitions are likely to act as future trends for the healthcare CMO market.

Which are the leading players operating in the healthcare CMO market?

Catalent, Inc and Lonza are the leading players operating in the healthcare CMO market.

What would be the estimated value of the healthcare CMO market by 2031?

US$ 385.26 billion would be the estimated value of the healthcare CMO market by 2031.

What is the expected CAGR of the healthcare CMO market?

13.7% is the CAGR of the healthcare CMO market.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.